Abstract |
Magnapen is a combination of two well-proven semi-snythetic penicillins which together offer the theoretical advantages of a broad spectrum of activity, good bioavailability and a low incidence of side-effects. It is of particular value in treating infections in the elderly. In this study the theory is borne out in practice in a population presenting special problems for which this combination seems particularly appropriate. Ninety-six patients have been treated with a course of Magnapen syrup. Of the total entered into the study, 73% of patients were clinically cured following therapy, with a further 19% improved. Clinical failure occurred in 8% of patients. Fifty-two patients were bacteriologically assessable, forty-seven of whom (90%) had infecting organisms cleared by therapy. Side-effects occurred in four patients (4%), one of whom had to discontinue therapy.
|
Authors | R S Middleton, H K Sinha |
Journal | The Journal of international medical research
(J Int Med Res)
Vol. 7
Issue 1
Pg. 52-6
( 1979)
ISSN: 0300-0605 [Print] England |
PMID | 421965
(Publication Type: Journal Article)
|
Chemical References |
- Drug Combinations
- Floxacillin
- Ampicillin
- Cloxacillin
|
Topics |
- Administration, Oral
- Aged
- Ampicillin
(administration & dosage, metabolism, therapeutic use)
- Bacterial Infections
(drug therapy)
- Biological Availability
- Cloxacillin
(analogs & derivatives)
- Drug Combinations
- Female
- Floxacillin
(administration & dosage, metabolism, therapeutic use)
- Humans
- Male
- Middle Aged
|